⌘K

Home/Filings/4/0001209191-21-069796

4//SEC Filing

Combs Andrew 4

Accession 0001209191-21-069796

CIK 0001678660other

View on SEC.gov Company Profile

Filed

Dec 14, 7:00 PM ET

Accepted

Dec 15, 5:21 PM ET

Size

6.4 KB

Accession

0001209191-21-069796

Insider Transaction Report

Form 4

Period: 2021-12-13

Prelude Therapeutics IncPRLD

Chief Chemistry Officer

Transactions

Purchase
Common Stock
2021-12-13$12.12/sh+4,000$48,480→ 264,380 total
Purchase
Common Stock
2021-12-14$11.60/sh+4,000$46,400→ 268,380 total

Footnotes (1)

[F1]Certain of the shares are subject to forfeiture to the Issuer if underlying vesting conditions are not met.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Prelude Therapeutics Inc

CIK 0001678660

Entity typeother

Related Parties

1

filerCIK 0001825005

Filing Metadata

Form type: 4
Filed: Dec 14, 7:00 PM ET
Accepted: Dec 15, 5:21 PM ET
Size: 6.4 KB

View on SEC.gov